We are live on ! Find out more
PAM

PVG Asset Management Portfolio holdings

AUM $173M
1-Year Est. Return 64.51%
This Fund
S&P 500
This Quarter Est. Return
-1.45%
1 Year Est. Return
+64.51%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$23M
AUM Growth
+$1.84M
Cap. Flow
+$2.37M
Cap. Flow %
10.33%
Top 10 Hldgs %
60.56%
Holding
59
New
13
Increased
12
Reduced
18
Closed
13

Sector Composition

Rank Sector Weight
1 Miscellaneous 48.58%
2 Healthcare 23.96%
3 Technology 9.17%
4 Consumer Discretionary 4.62%
5 Consumer Staples 3.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HSY icon
26
Hershey
HSY
$34.9B
$268K 1.17%
1,567
-134
-8% -$21.9K
CAG icon
27
Conagra Brands
CAG
$7.1B
$250K 1.09%
+9,389
New +$242K
FTSL icon
28
First Trust Senior Loan Fund ETF
FTSL
$2.43B
$247K 1.07%
5,402
+232
+4% +$10.7K
IWM icon
29
iShares Russell 2000 ETF
IWM
$77.6B
$246K 1.07%
1,231
-1,340
-52% -$291K
AVGO icon
30
Broadcom
AVGO
$1.65T
$219K 0.95%
1,310
-1,020
-44% -$216K
VKTX icon
31
Viking Therapeutics
VKTX
$3.68B
$219K 0.95%
+9,053
New +$286K
CKPT
32
DELISTED
Checkpoint Therapeutics
CKPT
$215K 0.93%
53,125
-70,350
-57% -$234K
RWAY icon
33
Runway Growth Finance
RWAY
$282M
$213K 0.93%
+20,550
New +$230K
AXP icon
34
American Express
AXP
$221B
$211K 0.92%
+786
New +$232K
GE icon
35
GE Aerospace
GE
$329B
$209K 0.91%
+1,042
New +$205K
IBD icon
36
Inspire Corporate Bond ETF
IBD
$505M
$205K 0.89%
+8,611
New +$203K
AGNC icon
37
AGNC Investment
AGNC
$12B
$201K 0.87%
20,967
-4,893
-19% -$48.9K
PIM
38
Franklin Master Intermediate Income Trust
PIM
$148M
$156K 0.68%
47,072
+985
+2% +$3.25K
GNLX icon
39
Genelux
GNLX
$115M
$78.7K 0.34%
+29,150
New +$109K
ALT icon
40
Altimmune
ALT
$642M
$70.1K 0.31%
+14,025
New +$88.8K
CALC icon
41
CalciMedica
CALC
$13.7M
$58K 0.25%
+6,077
New +$75.7K
VNDA icon
42
Vanda Pharmaceuticals
VNDA
$311M
$47.6K 0.21%
+10,375
New +$48.4K
BCAB
43
DELISTED
BIOATLA INC
BCAB
$22.5K 0.1%
1,300
+580
+81% +$12.4K
ADBE icon
44
Adobe
ADBE
$106B
-502
Closed -$223K
AIP icon
45
Arteris
AIP
$1.01B
-14,810
Closed -$151K
AVDL
46
DELISTED
Avadel Pharmaceuticals
AVDL
-34,040
Closed -$358K
BAC icon
47
Bank of America
BAC
$416B
-4,580
Closed -$201K
BXMX
48
DELISTED
Nuveen S&P 500 Buy-Write Income Fund
BXMX
-91,460
Closed -$1.28M
JACK icon
49
Jack in the Box
JACK
$281M
-5,715
Closed -$238K
JNJ icon
50
Johnson & Johnson
JNJ
$642B
-2,286
Closed -$331K

Similar funds

PVG Asset Management's Q1 2025 Portfolio in Review

As of Q1 2025, PVG Asset Management held 59 positions worth $23M, up 8.7% from $21.1M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

PVG Asset Management deployed $2.37M of net new capital in Q1 2025, opening 13 new positions and adding to 12 existing holdings. Its largest new stake was Direxion Daily S&P 500 Bear 1X ETF: 351,871 shares worth $4.08M.

By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, up from 35% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Pfizer, an estimated $360K trimmed.

  • PVG Asset Management's largest Q1 2025 buy was Direxion Daily S&P 500 Bear 1X ETF: 351,871 shares worth $4.08M.
  • PVG Asset Management added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q1 2025, an estimated $2.62M increase.
  • PVG Asset Management's biggest Q1 2025 reduction was Pfizer, cutting an estimated $360K.
  • PVG Asset Management fully exited Nuveen S&P 500 Buy-Write Income Fund in Q1 2025, selling an estimated $1.28M.
  • PVG Asset Management's ten largest holdings make up 61% of its $23M portfolio in Q1 2025.
  • PVG Asset Management opened 13 new positions and closed 13 in Q1 2025.
  • PVG Asset Management's portfolio value rose 8.7% quarter-over-quarter to $23M.

Based on PVG Asset Management's 13F filing for Q1 2025, filed 4 Jun 2025.